Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine

SWISS-MODEL: homology modelling of protein structures and complexes

Waterhouse, A. M., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,005 · see citing works

Protein Identification and Analysis Tools on the ExPASy Server

Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., & Bairoch, A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-890-0:571 · Cited by 10,133 · see citing works

The Phyre2 web portal for protein modeling, prediction and analysis

Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652 · see citing works

AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR

Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502 · see citing works

Verification of protein structures: Patterns of nonbonded atomic interactions

Colovos, C., & Yeates, T. O. (1993) · Protein Science · doi:10.1002/pro.5560020916 · Cited by 4,506 · see citing works

The PSIPRED protein structure prediction server

McGuffin, L. J., Bryson, K., & Jones, D. T. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.4.404 · Cited by 3,841 · see citing works

The Proteomics Protocols Handbook

Walker, J. M. (2005) · Humana Press eBooks · doi:10.1385/1592598900 · Cited by 3,600 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

The ClusPro web server for protein–protein docking

Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017) · Nature Protocols · doi:10.1038/nprot.2016.169 · Cited by 3,297 · see citing works

VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines

Doytchinova, I. A., & Flower, D. R. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-4 · Cited by 3,005 · see citing works

The Vienna RNA Websuite

Gruber, A. R., Lorenz, R., Bernhart, S. H., Neuböck, R., & Hofacker, I. L. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn188 · Cited by 2,717 · see citing works

Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.-M., et al. (2021) · doi:10.1101/2021.12.14.21267615 · Cited by 2,420 · see citing works

A semi‐empirical method for prediction of antigenic determinants on protein antigens

Kolaskar, A. S., & Tongaonkar, P. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80535-q · Cited by 1,493 · see citing works

The HADDOCK web server for data-driven biomolecular docking

de Vries, S. J., van Dijk, M., & Bonvin, A. M. J. J. (2010) · Nature Protocols · doi:10.1038/nprot.2010.32 · Cited by 1,387 · see citing works

Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

Emini, E. A., Hughes, J. V., Perlow, D. S., & Boger, J. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.836-839.1985 · Cited by 1,252 · see citing works

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073 · see citing works

AllerTOP - a server for in silico prediction of allergens

Dimitrov, I., Flower, D. R., & Doytchinova, I. A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s6-s4 · Cited by 517 · see citing works

NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction

Nielsen, M., & Lund, O. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-296 · Cited by 513 · see citing works

A backbone-based theory of protein folding

Rose, G. D., Fleming, P. J., Banavar, J. R., & Maritan, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606843103 · Cited by 478 · see citing works

3Drefine: an interactive web server for efficient protein structure refinement

Bhattacharya, D., Nowotny, J., Cao, R., & Cheng, J. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw336 · Cited by 416 · see citing works

NetMHCcons: a consensus method for the major histocompatibility complex class I predictions

Karosiene, E., Lundegaard, C., Lund, O., & Nielsen, M. (2011) · Immunogenetics · doi:10.1007/s00251-011-0579-8 · Cited by 397 · see citing works

Evaluation of candidate vaccine approaches for MERS-CoV

Wang, L., Shi, W., Joyce, M. G., Modjarrad, K., Zhang, Y., Leung, K., Lees, C. R., Zhou, T., Yassine, H. M., Kanekiyo, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8712 · Cited by 300 · see citing works

Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification

Andreatta, M., Karosiene, E., Rasmussen, M., Stryhn, A., Buus, S., & Nielsen, M. (2015) · Immunogenetics · doi:10.1007/s00251-015-0873-y · Cited by 289 · see citing works

PROCHECK: validation of protein-structure coordinates

Laskowski, R. A., MacArthur, M. W., & Thornton, J. M. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000882 · Cited by 260 · see citing works

Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

Suschak, J. J., Williams, J. A., & Schmaljohn, C. S. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1330236 · Cited by 240 · see citing works

OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear

Thakur, V., & Ratho, R. K. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27541 · Cited by 235 · see citing works

Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes

Paul, S., Arlehamn, C. S. L., Scriba, T. J., Dillon, M., Oseroff, C., Hinz, D., McKinney, D. M., Pro, S. C., Sidney, J., Peters, B., et al. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.03.022 · Cited by 209 · see citing works

Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus

Hajighahramani, N., Nezafat, N., Eslami, M., Negahdaripour, M., Rahmatabadi, S. S., & Ghasemi, Y. (2016) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2016.12.010 · Cited by 195 · see citing works

An introduction to epitope prediction methods and software

Yang, X., & Yu, X. (2008) · Reviews in Medical Virology · doi:10.1002/rmv.602 · Cited by 191 · see citing works

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Pollock, K. M., Cheeseman, H. M., Szubert, A. J., Libri, V., Boffito, M., Owen, D., Bern, H., McFarlane, L. R., O'Hara, J., Lemm, N.-M., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101262 · Cited by 173 · see citing works

Predicting HLA CD4 Immunogenicity in Human Populations

Dhanda, S. K., Karosiene, E., Edwards, L., Grifoni, A., Paul, S., Andreatta, M., Weiskopf, D., Sidney, J., Nielsen, M., Peters, B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01369 · Cited by 155 · see citing works

The Impact of Bioinformatics on Vaccine Design and Development

María, R. R., Castelán-Vega, J. A., Jiménez-Alberto, A., Paulina, M. G., & Aparicio‐Ozores, G. (2017) · InTech eBooks · doi:10.5772/intechopen.69273 · Cited by 144 · see citing works

T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆

Weber, C. A., Mehta, P. J., Ardito, M. T., Moise, L., Martin, B., & Groot, A. S. D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.001 · Cited by 110 · see citing works

Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix

Schafer, J. L. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00173-x · Cited by 106 · see citing works

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability

Voigt, E. A., Gerhardt, A., Hanson, D., Jennewein, M. F., Battisti, P., Reed, S., Singh, J., Mohamath, R., Bakken, J., Beaver, S., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00549-y · Cited by 89 · see citing works

Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study

Nosrati, M., Hajizade, A., Nazarian, S., Amani, J., Vansofla, A. N., & Tarverdizadeh, Y. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.09.018 · Cited by 68 · see citing works

In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes

Moise, L., McMurry, J. A., Buus, S., Frey, S. E., Martin, W. D., & Groot, A. S. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.018 · Cited by 66 · see citing works

A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines

Pourseif, M. M., Parvizpour, S., Jafari, B., Dehghani, J., Naghili, B., & Omidi, Y. (2020) · Bioimpacts · doi:10.34172/bi.2021.11 · Cited by 63 · see citing works

Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus)

Azim, K. F., Hasan, M., Hossain, M. N., Somana, S. R., Hoque, S. F., Bappy, M. N. I., Chowdhury, A. T., & Lasker, T. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.103936 · Cited by 61 · see citing works

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine

Low, J. G., de Alwis, R., Chen, S., Kalimuddin, S., Leong, Y. S., Mah, T. K. L., Yuen, N., Tan, H. C., Zhang, S. L., Sim, J. X. Y., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00590-x · Cited by 61 · see citing works

Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach

Abdulla, F., Adhikari, U. K., & Uddin, M. K. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103791 · Cited by 54 · see citing works

Omicron is supercharging the COVID vaccine booster debate

Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-03592-2 · Cited by 54 · see citing works

Computational vaccinology and epitope vaccine design by immunoinformatics

Khalili, S., Jahangiri, A., Borna, H., Zanoos, K. A., & Amani, J. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.3.4 · Cited by 49 · see citing works

MacVector: Integrated Sequence Analysis for the Macintosh

Rastogi, P. A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-192-2:47 · Cited by 45 · see citing works

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells

Dwivedi, A., Karulkar, A., Ghosh, S., Srinivasan, S., Kumbhar, B. V., Jaiswal, A. K., Kizhakeyil, A., Asija, S., Rafiq, A., Kumar, S., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0476 · Cited by 33 · see citing works

Design of a predicted MHC restricted short peptide immunodiagnostic and vaccine candidate for Fowl adenovirus C in chicken infection

Farvet s.A.C. Carretera Panamericana Sur Nº 766 Km 198.5, C. A. I. –. P., Valdivia-Olarte, H., Laboratorio de Bioinformática y Biología Molecular, L. D. I. Y. D., Requena, D., Farvet s.A.C. Carretera Panamericana Sur Nº 766 Km 198.5, C. A. I. –. P. L. D. B. Y. B. M., Ramírez, M., Farvet s.A.C. Carretera Panamericana Sur Nº 766 Km 198.5, C. A. I. –. P. L. D. B. Y. B. M., Saravia, L. E., Farvet s.A.C. Carretera Panamericana Sur Nº 766 Km 198.5, C. A. I. –. P., Izquierdo, R., et al. (2015) · Bioinformation · doi:10.6026/97320630011460 · Cited by 28 · see citing works

An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice

Bounds, C. E., Terry, F. E., Moise, L., Hannaman, D., Martin, W. D., Groot, A. S. D., Suschak, J. J., Dupuy, L. C., & Schmaljohn, C. S. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1329788 · Cited by 28 · see citing works

Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq

Rashid, P. M. A., & Salih, G. F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07545-4 · Cited by 26 · see citing works

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against COVID-19: COVAC1, a Phase I, Dose-Ranging TrialPreprint

Pollock, K. M., Cheeseman, H. M., Szubert, A. J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3859294 · Cited by 24 · see citing works

Modeling of MT. P495, an mRNA-based vaccine against the phosphate-binding protein PstS1 of Mycobacterium tuberculosis

Shahrear, S., & Islam, A. B. M. M. K. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10515-4 · Cited by 24 · see citing works

Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: an in silico approach

Tehrani, S. S., Gharibi, S., Movahedpour, A., Goodarzi, G., Jamali, Z., Khatami, S. H., Maniati, M., Ranjbar, M., Shabaninejad, Z., Savardashtaki, A., et al. (2020) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1812640 · Cited by 22 · see citing works

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines

Elliott, T., Cheeseman, H. M., Evans, A. B., Day, S., McFarlane, L. R., O’Hara, J., Kalyan, M., Amini, F., Cole, T., Winston, A., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010885 · Cited by 21 · see citing works

Structure prediction and molecular docking studies of aromatic hydrocarbon sensing proteins TbuT, HbpR and PhnR to detect priority pollutants

Patel, R., Chudasama, R., Solanki, R., Patel, P., Parmar, K., & Munshi, N. S. (2019) · Journal of Environmental Science and Health Part A · doi:10.1080/10934529.2019.1672457 · Cited by 19 · see citing works

Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development

Amat-ur-Rasool, H., Saghir, A., & Idrees, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119854 · Cited by 16 · see citing works

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

Saraf, A., Gurjar, R., Kaviraj, S., Kulkarni, A., Kumar, D., Kulkarni, R., Virkar, R., Krishnan, J., Yadav, A., Baranwal, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02955-2 · Cited by 66 · see citing works

Transfection via RNA-Based Nanoparticles: Comparing Encapsulation vs Adsorption Approaches of RNA Incorporation

Laturski, A. E., Dulay, M. T., Perry, J. L., & DeSimone, J. M. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00028 · Cited by 6 · see citing works

Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19

Kumar, D., Gaikwad, K., Gunnale, R., Vishwakarma, S., Shukla, S., Srivastava, S., Gopal, J., Vaidya, B., Saraf, A., Gurjar, R., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01076-2 · Cited by 5 · see citing works

Combinative workflow for mRNA vaccine development

Khanzode, R., Soni, G., Srivastava, S., Pawar, S. P., Wadapurkar, R. M., & Singh, A. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101766 · Cited by 2 · see citing works

Leveraging Next-Generation Sequencing Application from Identity to Purity Profiling of Nucleic Acid-Based Products

Wadapurkar, R. M., Deo, S., Khanzode, R., & Singh, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics17010030

Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform

Laturski, A. E., Durán, V., Schaar, B. T., Dulay, M. T., Einav, S., & DeSimone, J. M. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00069

Combinative workflow for mRNA vaccine development

Khanzode, R., Soni, G., Srivastava, S., Pawar, S. P., Wadapurkar, R. M., & Singh, A. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101766 · Cited by 2 · see citing works

Structure-guided design of a bivalent SARS-CoV-2 mRNA vaccine with NTD stabilizing mutations enhances broad immunity

Yeo, J., Yun, M.-R., Kim, S.-Y., Seok, J.-H., Jeon, J. H., Lee, T., Kim, J., Kim, K., Park, M., Kim, D., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718740

In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology

Li, V., Lee, C., Yoo, D., Cho, S., & Kim, H. (2022) · Genes & Genomics · doi:10.1007/s13258-022-01255-8 · Cited by 8 · see citing works

Robust and rapid pipeline for the development of mRNA vaccine for the fast-emerging SARS-CoV-2 variantsPreprint

Soni, G., Khanzode, R., Srivast, S., Pawar, S. P., Wadapurkar, R. M., Singh, S. S., & Singh, A. (2022) · Research Square · doi:10.21203/rs.3.rs-2074769/v1

Immunogenicity and Protection of mRNA Vaccine Encoding Spike Protein of SARS-CoV-2 Omicron-XEC Subvariant

Guan, X., Cho, H., Liu, Q., Qian, S., & Du, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104218